PHARMACEUTICAL COMPOSITION
The present invention provides a pharmaceutical composition comprising(a) a triblock copolymer having the formula:PLAv-PEGw-PLAxwherein v and x are the number of repeat units ranging from 1 to 3,000 and w is the number of repeat units ranging from 3 to 300 and v=x or v≠x in an amount of 22 to 34 w/w...
Saved in:
Main Authors | , , |
---|---|
Format | Patent |
Language | English |
Published |
18.04.2024
|
Subjects | |
Online Access | Get full text |
Cover
Loading…
Summary: | The present invention provides a pharmaceutical composition comprising(a) a triblock copolymer having the formula:PLAv-PEGw-PLAxwherein v and x are the number of repeat units ranging from 1 to 3,000 and w is the number of repeat units ranging from 3 to 300 and v=x or v≠x in an amount of 22 to 34 w/w % of the total composition;(b) a diblock copolymer having the formula:mPEGy-PLAzwherein y and z are the number of repeat units with y ranging from 2 to 250 and z ranging from 1 to 3,000 in an amount of 5 to 9 w/w % of the total composition;(c) tacrolimus or a pharmaceutically acceptable salt, hydrate or solvate thereof in an amount of 8 to 32 w/w % of the total composition; and(d) organic solvent in an amount of 30 to 62 w/w % of the total composition. |
---|---|
Bibliography: | Application Number: US202118267637 |